In a recent publication from Toxicologic Pathology, Neurosetta’s RosetteArray technology was highlighted as an exemplar of a complex in vitro model (CIVMs) that offers the potential to increase the clinical relevance toxicity assessments and reduce the reliance on animals in drug development.
Listen to a podcast now from Sage Toxicologic Pathway & Veterinary Science: Complex In Vitro Model Characterization for Context of Use in Toxicologic Pathology: Use Cases by Collaborative Teams of Biologists, Bioengineers, and Pathologists.
